AIM
INO icon

ARK Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

ARK Investment Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-64,286
Closed -$20.8M – 228
2020
Q2 		$20.8M Sell
64,286
-72,208
-53% -$11.6M 0.22% 60
2020
Q1 		$12.2M Sell
136,494
-245,587
-64% -$15.1M 0.3% 54
2019
Q4 		$15.1M Buy
382,081
+30,190
+9% +$909K 0.38% 44
2019
Q3 		$8.66M Buy
351,891
+22,306
+7% +$678K 0.19% 59
2019
Q2 		$11.6M Buy
329,585
+85,452
+35% +$3.39M 0.29% 48
2019
Q1 		$10.9M Buy
244,133
+86,996
+55% +$4.38M 0.31% 47
2018
Q4 		$7.54M Sell
157,137
-2,619
-2% -$159K 0.31% 50
2018
Q3 		$10.7M Buy
159,756
+60,201
+60% +$3.35M 0.32% 57
2018
Q2 		$4.68M Buy
99,555
+44,187
+80% +$2.44M 0.17% 65
2018
Q1 		$3.13M Buy
55,368
+31,512
+132% +$1.71M 0.16% 71
2017
Q4 		$1.18M Buy
23,856
+11,907
+100% +$738K 0.09% 89
2017
Q3 		$909K Buy
11,949
+6,457
+118% +$480K 0.11% 91
2017
Q2 		$517K Buy
5,492
+2,428
+79% +$208K 0.1% 81
2017
Q1 		$243K Buy
3,064
+462
+18% +$36.8K 0.07% 82
2016
Q4 		$217K Buy
+2,602
New +$235K 0.08% 76

Other funds holding INO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ARK Investment Management's INO Position: Q3 2020 in Review

ARK Investment Management sold out of Inovio Pharmaceuticals (INO) in Q3 2020, closing a stake of 64,286 shares — an estimated $20.8M sold.

ARK Investment Management first reported a position in INO in Q4 2016 and held it in 15 quarters. The position peaked at $20.8M in Q2 2020. 212 funds tracked by Wall St. Rank hold INO as of Q3 2020.

  • ARK Investment Management reported no remaining Inovio Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • ARK Investment Management sold 64,286 Inovio Pharmaceuticals shares in Q3 2020, an estimated $20.8M.
  • ARK Investment Management first reported a position in Inovio Pharmaceuticals in Q4 2016 and held it in 15 quarters.
  • ARK Investment Management's Inovio Pharmaceuticals position peaked at $20.8M in Q2 2020.
  • 212 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2020.

Based on ARK Investment Management's 13F filing for Q3 2020, filed 30 Oct 2020.